Ferradini L, Mackensen A, Genevée C, Bosq J, Duvillard P, Avril M F, Hercend T
Laboratoire d'Hémato-Immunologie, Institut National de la Santé et de la Recherche Médicale U333, Villejuif, France.
J Clin Invest. 1993 Mar;91(3):1183-90. doi: 10.1172/JCI116278.
Malignant melanomas are often infiltrated by T lymphocytes. It is postulated that the presence of tumor-infiltrating lymphocytes (TIL) reflects ongoing immune responses against transformed cells. Such "responses" appear generally inefficient with the potential exception of infrequent clinical situations characterized by spontaneous tumor regression. We have characterized here the molecular structure of the T cell receptor beta chain expressed by TILs in a case of regressive melanoma. Advantage was taken of the PCR technology to study T lymphocytes directly without cell culture. Experimentally validated V beta subfamily specific primers were used to evaluate the V beta usage in TILs and control samples. Our results reveal that clonal T cell populations, precisely defined by their V-D-J junctional sequences, are amplified at the tumor site. The existence of such local antigen-driven selections support the hypothesis that antitumor responses may indeed take place in regressive melanoma.
恶性黑色素瘤常被T淋巴细胞浸润。据推测,肿瘤浸润淋巴细胞(TIL)的存在反映了针对转化细胞的持续免疫反应。除了以肿瘤自发消退为特征的罕见临床情况外,这种“反应”通常效率低下。我们在此描述了一例消退性黑色素瘤中TIL表达的T细胞受体β链的分子结构。利用PCR技术直接研究T淋巴细胞,无需细胞培养。使用经过实验验证的Vβ亚家族特异性引物来评估TIL和对照样本中的Vβ使用情况。我们的结果显示,由其V-D-J连接序列精确定义的克隆性T细胞群体在肿瘤部位被扩增。这种局部抗原驱动选择的存在支持了抗肿瘤反应确实可能在消退性黑色素瘤中发生的假说。